2008
DOI: 10.1157/13115821
|View full text |Cite
|
Sign up to set email alerts
|

Retirada de la anticoagulación en el síndrome antifosfolípido primario cuando se negativizan los anticuerpos anticardiolipina

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(12 citation statements)
references
References 11 publications
1
11
0
Order By: Relevance
“…Out of 1006 screened studies, a total of four [3][4][5][6] met the inclusion criteria, including 47 thrombotic APS patients with persistently aPL seroconversion. Three out of four studies, including 23 thrombotic APS patients, described discontinuation of anticoagulation therapy after aPL seroconversion.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Out of 1006 screened studies, a total of four [3][4][5][6] met the inclusion criteria, including 47 thrombotic APS patients with persistently aPL seroconversion. Three out of four studies, including 23 thrombotic APS patients, described discontinuation of anticoagulation therapy after aPL seroconversion.…”
Section: Resultsmentioning
confidence: 99%
“…Two studies [4,5] included patients with 2 consecutive aPL seroconversion, however one of those studies [5] retested patients to confirm aPL disappearance after five years. Two studies [6,7] did not define the aPL negativization, however one study [7], reported patients with at least nine negative determinations of…”
Section: Definition Of Apl Negativizationmentioning
confidence: 99%
See 2 more Smart Citations
“…On the other hand, a recent study analyzed the outcome of a series of 10 cases with definite APS (defined by venous thrombosis and aCL positivity on at least two occasions), who had been treated with warfarin for a minimum of 12 months and who eventually became aPL negative. 51 An interesting finding was the absence of recurrent thrombosis after anticoagulation withdrawal during the 21 months of follow-up.…”
Section: Duration Of Anticoagulation Therapy In Patients With Apsmentioning
confidence: 96%